Thinking Outside the Cleft to Understand Synaptic Activity: Contribution of the Cystine-Glutamate Antiporter (System xc−) to Normal and Pathological Glutamatergic Signaling
Open accessAbstract
System x(c)(-) represents an intriguing target in attempts to understand the pathological states of the central nervous system. Also called a cystine-glutamate antiporter, system x(c)(-) typically functions by exchanging one molecule of extracellular cystine for one molecule of intracellular glutamate. Nonvesicular glutamate released during cystine-glutamate exchange activates extrasynaptic glutamate receptors in a manner that shapes synaptic activity and plasticity. These findings contribute to the intriguing possibility that extracellular glutamate is regulated by a complex network of release and reuptake mechanisms, many of which are unique to glutamate and rarely depicted in models of excitatory signaling. Because system x(c)(-) is often expressed on non-neuronal cells, the study of cystine-glutamate exchange may advance the emerging viewpoint that glia are active contributors to information processing in the brain. It is noteworthy that system x(c)(-) is at the interface between excitatory signaling and oxidative stress, because the uptake of cystine that results from cystine-glutamate exchange is critical in maintaining the levels of glutathione, a critical antioxidant. As a result of these dual functions, system x(c)(-) has been implicated in a wide array of central nervous system diseases ranging from addiction to neurodegenerative disorders to schizophrenia. In the current review, we briefly discuss the major cellular components that regulate glutamate homeostasis, including glutamate release by system x(c)(-). This is followed by an in-depth discussion of system x(c)(-) as it relates to glutamate release, cystine transport, and glutathione synthesis. Finally, the role of system x(c)(-) is surveyed across a number of psychiatric and neurodegenerative disorders.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Astrocytes form microdomains modulating glutamatergic synapses and extrasynaptic glutamate receptors, and CSPGs control lateral diffusion of cell surface receptors, extrasynaptic diffusion of negatively charged transmitters such as glutamate, and expression of glial transmitter transporters.
“This possibility is in line with growing evidence indicating that astrocytes form microdomains modulating glutamatergic synapses and extrasynaptic glutamate receptors, and that CSPGs (cell surface bound and as part of ECM) control (i) lateral diffusion of cell surface receptors, (ii) the extrasynaptic diffusion of negatively charged transmitters such as glutamate and (iii) the expression of glial”
From Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala (2015) · cites this paper as [102]
NAC boosts the astrocytic cystine/glutamate antiporter, increasing cystine uptake and glutamate release outside cells.
“Finally, NAC upregulates the activity of the astrocytic cystine/glutamate antiporter, leading to cellular entry of cystine (which can be reduced to cysteine and incorporated into GSH) and extracellular release of glutamate (Bridges et al., 2012).”
From Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? (2016) · cites this paper as Bridges et al., 2012
NAC can regulate glutamatergic neurotransmission.
“In the present review, we will however focus on NAC because it has antioxidant and anti-inflammatory properties, and can regulate glutamatergic neurotransmission.”
From Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? (2016) · cites this paper as Bridges et al., 2012
The citation lists haven’t been fetched yet
References 380 · Cited by 205
- Authors
- Bridges, R., Lutgen, V., Lobner, D., & Baker, D. A.
- Affiliations
- Marquette University (US)
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 64
- Issue
- 3
- Pages
- 780-802
- ISSN
- 0031-6997 (ISSN-L)
- PMC
- PMC3400835
- OpenAlex
- W2133994038
- Cited by
- 205
- References
- 380
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 21 · 2023: 14 · 2022: 20 · 2021: 13 · 2020: 17 · 2019: 11 · 2018: 14 · 2017: 16 · 2016: 9 · 2015: 19 · 2014: 17 · 2013: 11 · 2012: 2
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Pharmacological Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- e-Publications@Marquette (Marquette University) (submittedVersion)
- Funders
- National Institute of Mental Health (MH083417, R44MH083417, R43MH083417)
- National Institute on Drug Abuse (DA025617, R01DA025617)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Keywords
- system xc-, SLC7A11, glutamate homeostasis, cystine transport, glutathione synthesis, oxidative stress, synaptic plasticity, neurodegenerative diseases, schizophrenia, addiction, mental illness
- MeSH terms
- Animals, Mental Disorders, Biological Transport, Central Nervous System, Cystine, Glutathione, Humans, Synapses, Signal Transduction, Glutamic Acid, Neurodegenerative Diseases, Neurotoxicity Syndromes, Amino Acid Transport System y+
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review